Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics, Biognosys Partner on Proteomics for Biopharma Development

NEW YORK – NeoGenomics announced on Monday that it has entered a global strategic partnership agreement with Swiss proteomics firm Biognosys for biopharmaceutical research and development. 

The agreement will encompass multiple strategic and commercial initiatives, including NeoGenomics' labs offering access to Biognosys proteomics platforms, medical and scientific affairs joint presentations and discussions, and global scientific and technical initiatives, NeoGenomics said in a statement.

Financial and other terms of the deal were not disclosed.

"Partnering with Biognosys gives us the added advantage of expanding into proteomics, data analytics, and subsequent actionable results, not only in early discovery and translational research but ultimately, in clinical trials impacting patient care," Gina Wallar, NeoGenomics' president of pharma services, said in a statement.

The companies have designed a multi-modality approach for protein analysis of tumor samples from late-stage melanoma patients who have been treated with immune checkpoint inhibitors, NeoGenomics said. The collaboration combines Biognosys' TrueDiscovery proteomics platform, which is based on proprietary mass spectrometry technology, with NeoGenomics' proprietary MultiOmyx platform for multiplexed immunofluorescence spatial tissue analysis, the Fort Myers, Florida-based firm added.

Data from the collaboration will be presented at the American Association for Cancer Research this week.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.